Live Breaking News & Updates on Geron Corporation Nasdaq
Stay updated with breaking news from Geron corporation nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast status
07.06.2024 - Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved RYTELO (imetelstat) for the . Seite 1 ....
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.